Glucagon · source year
4 selected, source-linked Glucagon records carrying a 2000 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
4 selected records.
2 represented types.
4 distinct public records.
Cited chronology
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 5198467 at 2026-07-30T23:27:29.856Z. PubMed recorded a metadata revision date of 2000-12-18 and an Entrez history date of 1970-02-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 5501122 at 2026-07-30T23:27:29.856Z. PubMed recorded a metadata revision date of 2000-12-18 and an Entrez history date of 1970-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Literature metadata
PeptideScanner retained PubMed bibliographic metadata for PMID 801696 at 2026-07-30T23:27:29.851Z. PubMed recorded a metadata revision date of 2000-12-18 and an Entrez history date of 1976-01-01. PeptideScanner associated this retained record with the identity slug glucagon. These dates describe PubMed metadata history, not the article's original publication date.
Source: PubMed ↗
Regulatory
The Federal Register published notice 00-1872, attributed to FDA and its parent HHS department, on 2000-01-27. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; GlucaGen®,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.
Source: Federal Register via GovInfo ↗